Botanical species · safety record

Magnolia salicifolia

The EFSA Compendium of Botanicals holds 55 constituent measurements for Magnolia salicifolia. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Magnolia salicifolia (Siebold & Zucc.) Maxim.

55Constituent measurements
0Safety records
12Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Methyleugenol6
  • Asarone3
  • Camphor3
  • Methylisoeugenol3
  • 1,8-cineole2
  • 4-hydroxybenzaldehyde2
  • Benzaldehyde2
  • Coclaurine2
  • Estragole2
  • Myristicin2

Plant parts

  • Bud29
  • Flower10
  • Aerial part of plants6
  • Leaves5
  • Bark2
  • Fruit unspecified2
  • Unspecified1

Preparations

  • Solvent extraction47
  • Essential oil6

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
AsaroneBudSolvent extraction—GC-MSResolve DOI
BenzaldehydeBudSolvent extraction—GC-MSResolve DOI
Benzene-1,2-diolBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CamphorBudSolvent extraction—GC-MSResolve DOI
Cinnamyl alcoholBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CoclaurineBud——UnspecifiedResolve DOI
CoclaurineBudSolvent extraction—UnspecifiedResolve DOI
ConiferinBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
FenchoneBudSolvent extraction—GC-MSResolve DOI
IsosafroleBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
MethyleugenolBudSolvent extraction—GC-MSResolve DOI
MethyleugenolBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
MyristicinBudSolvent extraction—GC-MSResolve DOI
MyristicinBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
N-methylcoclaurineBudSolvent extraction—UnspecifiedResolve DOI
NeolignansBudSolvent extraction—GC-MSResolve DOI
PinoresinolBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
ReticulineBud——UnspecifiedResolve DOI
ReticulineBudSolvent extraction—UnspecifiedResolve DOI
SafroleBudSolvent extraction—GC-MSResolve DOI
SafroleBudSolvent extraction—Standard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
(+)-diasyringaresinolBudSolvent extraction0.003 PercentHPLC-UVNo resolvable identifier
(+)-epiaschantinBudSolvent extraction1.5479 PercentHPLC-UVNo resolvable identifier
(+)-epieudesmineBudSolvent extraction0.7711 PercentHPLC-UVNo resolvable identifier
1,8-cineoleAerial part of plantsEssential oil≥ 1.2 PercentGaschromatography (GC)No resolvable identifier
1,8-cineoleAerial part of plantsEssential oil≤ 34 PercentGaschromatography (GC)No resolvable identifier
4-hydroxybenzaldehydeFlowerSolvent extraction≥ 14.7 PercentGC-MSNo resolvable identifier
4-hydroxybenzaldehydeFlowerSolvent extraction≤ 18.6 PercentGC-MSNo resolvable identifier
AsaroneFlowerSolvent extraction≤ 19.7 PercentGC-MSNo resolvable identifier
AsaroneFlowerSolvent extraction≥ 6.3 PercentGC-MSNo resolvable identifier
BenzaldehydeFlowerSolvent extraction—Chromatographic testsNo resolvable identifier
CamphorAerial part of plantsEssential oil≥ 0.2 PercentGaschromatography (GC)No resolvable identifier
CamphorAerial part of plantsEssential oil≤ 2 PercentGaschromatography (GC)No resolvable identifier
CostunolideFruit unspecifiedSolvent extraction—High Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier
Epi-magnolin aBudSolvent extraction0.0022 PercentHPLC-UVNo resolvable identifier
EstragoleAerial part of plantsEssential oil≥ 0.5 PercentGaschromatography (GC)No resolvable identifier
EstragoleAerial part of plantsEssential oil≤ 4.8 PercentGaschromatography (GC)No resolvable identifier
EugenolLeavesSolvent extraction0.2 PercentGC-MSNo resolvable identifier
KobusinBudSolvent extraction0.0029 PercentHPLC-UVNo resolvable identifier
LiriodenineLeavesSolvent extraction—Chromatographic testsNo resolvable identifier

40 of 55 records are shown, ordered so that records carrying a resolvable reference come first.

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. KIKUCHI, T., KADOTA, S., YANADA, K., TANAKA, K., WATANABE, K., YOSHIZAKI, M., YOKOI, T., SHINGU, T. ISOLATION AND STRUCTURE OF MAGNOSALIN AND MAGNOSHININ, NEW NEOLIGNANS FROM MAGNOLIA-SALICIFORIA MAXIM . Chemical & pharmaceutical bulletin, 1983, vol. 31, no. 3, p. 1112-1114.
  2. TSURUGA, T., EBIZUKA, Y., NAKAJIMA, J., CHUN, YT., NOGUCHI, H., IITAKA, Y., SANKAWA, U. BIOLOGICALLY-ACTIVE CONSTITUENTS OF MAGNOLIA-SALICIFOLIA - INHIBITORS OF INDUCED HISTAMINE-RELEASE FROM RAT MAST-CELLS . Chemical & pharmaceutical bulletin, 1991, vol. 39, no. 12, p. 3265-3271.
  3. FURMANOWA, M., JOZEFOWICZ, J. ALKALOIDS AS TAXONOMIC MARKERS IN SOME SPECIES OF MAGNOLIA L AND LIRIODENDRON L . Acta societatis botanicorum poloniae, 1980, vol. 49, no. 4, p. 527-535.
  4. TSURUGA, T., EBIZUKA, Y., NAKAJIMA, J., CHUN, YT., NOGUCHI, H., IITAKA, Y., SANKAWA, U. ISOLATION OF A NEW NEOLIGNAN, MAGNOSALICIN, FROM MAGNOLIA-SALICIFOLIA. Tetrahedron letters, 1984, vol. 25, no. 37, p. 4129-4132. DOI
  5. Zuma, Hiroshi., Toyota, Masao., Asakawa, Yoshinori., Kawano, Shoichi. Naphthalene- a constituent of Magnolia flowers. Phytochemistry (oxford), 1996, vol. 42, no. 4, p. 999-1004.
  6. FUJITA, S., FUJITA, Y. COMPARATIVE BIOCHEMICAL AND CHEMO-TAXONOMICAL STUDIES OF ESSENTIAL OILS OF MAGNOLIA-SALICIFOLIA MAXIM .2. . Chemical & pharmaceutical bulletin, 1974, vol. 22, no. 3, p. 707-709.
  7. Fang, Zhe., Shen, Chang Min., Moon, Dong Cheul., Son, Kun Ho., Son, Jong Keun., Woo, Mi Hee. Quantitative and pattern recognition analyses for the quality evaluation of Magnoliae Flos by HPLC. Bulletin of the korean chemical society, 2010, vol. 31, no. 11, p. 3371-3381.
  8. Kelm, MA., Nair, MG., Schutzki, RA. Mosquitocidal compounds from Magnolia salicifolia. International journal of pharmacognosy, 1997, vol. 35, no. 2, p. 84-90.
  9. Li, Jun., Tanaka, Makoto., Kurasawa, Katsuki., Ikeda, Tsuyoshi., Nohara, Toshihiro. Studies of the chemical constituents of the flower buds of Magnolia kobus and M-salicifolia . Journal of natural medicines, 2007, vol. 61, no. 2, p. 222-223. DOI
  10. Tomita, Masao., Nakano, Tatsuhiko. Alkaloids of magnoliaceous plants. III. Alkaloids of Magnolia salicifolia. Yakugaku zasshi, 1952, vol. 72, p. 197-203.
  11. KIMURA, I., CHUI, LH., FUJITANI, K., KIKUCHI, T., KIMURA, M. INOTROPIC EFFECTS OF (+/-)-HIGENAMINE AND ITS CHEMICALLY RELATED COMPONENTS, (+)-R-COCLAURINE AND (+)-S-RETICULINE, CONTAINED IN THE TRADITIONAL SINO-JAPANESE MEDICINES BUSHI AND SHIN-I IN ISOLATED GUINEA-PIG PAPILLARY-MUSCLE . Japanese journal of pharmacology, 1989, vol. 50, no. 1, p. 75-78. DOI
  12. KIMURA, I., KIMURA, M., YOSHIZAKI, M., YANADA, K., KADOTA, S., KIKUCHI, T. NEUROMUSCULAR BLOCKING ACTION OF ALKALOIDS FROM A JAPANESE CRUDE DRUG SHIN-I (FLOS MAGNOLIAE) IN FROG SKELETAL-MUSCLE . Planta medica, 1983, vol. 48, no. 1, p. 43-47. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue